Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May;21(5):1240-1245.
doi: 10.1038/s41436-018-0319-7. Epub 2018 Oct 8.

Pitfalls of clinical exome and gene panel testing: alternative transcripts

Dale L Bodian  1 , Prachi Kothiyal  2 , Natalie S Hauser  2
Affiliations
Free article

Pitfalls of clinical exome and gene panel testing: alternative transcripts

Dale L Bodian et al. Genet Med. 2019 May.
Free article

Erratum in

Abstract

Purpose: Clinical exome and gene panel testing can provide molecular diagnoses for patients with rare Mendelian disorders, but for many patients these tests are nonexplanatory. We investigated whether interrogation of alternative transcripts in known disease genes could provide answers for additional patients.

Methods: We integrated alternative transcripts for known neonatal epilepsy genes with RNA-Seq data to identify brain-expressed coding regions that are not evaluated by popular neonatal epilepsy clinical gene panel and exome tests.

Results: We found brain-expressed alternative coding regions in 89 (30%) of 292 neonatal epilepsy genes. The 147 regions encompass 15,713 bases that are noncoding in the primary transcripts analyzed by the clinical tests. Alternative coding regions from at least 5 genes carry reported pathogenic variants. Three candidate variants in these regions were identified in public exome data from 337 epilepsy patients. Incorporating alternative transcripts into the analysis of neonatal epilepsy genes in 44 patient genomes identified the pathogenic variant for the epilepsy case and 2 variants of uncertain significance (VUS) among the 43 control cases.

Conclusion: Assessment of alternative transcripts in exon-based clinical genetic tests, including gene panel, exome, and genome sequencing, may provide diagnoses for patients for whom standard testing is unrevealing, without introducing many VUS.

Keywords: alternative transcripts; diagnostic yield; epilepsy; exome sequencing; gene panel testing.

PubMed Disclaimer

References

    1. Bodian DL, Solomon BD, Khromykh A, et al. Diagnosis of an imprinted-gene syndrome by a novel bioinformatics analysis of whole-genome sequences from a family trio. Mol Genet Genomic Med. 2014;2:530–538. - DOI
    1. Palomares-Bralo M, Vallespin E, Del Pozo A, et al. Pitfalls of trio-based exome sequencing: imprinted genes and parental mosaicism-MAGEL2 as an example. Genet Med. 2017;19:1285–1286. - DOI
    1. Aten E, Fountain MD, van Haeringen A, Schaaf CP, Santen GW. Imprinting: the Achilles heel of trio-based exome sequencing. Genet Med. 2016;18:1163–1164. - DOI
    1. Bodian DL, Schreiber JM, Vilboux T, Khromykh A, Hauser NS. Mutation in an alternative transcript of CDKL5 in a boy with early onset seizures. Cold Spring Harb Mol Case Stud. 2018;4:a002360. - DOI - PubMed - PMC
    1. Epilepsy Genetics Initiative. De novo variants in the alternative exon 5 of SCN8A cause epileptic encephalopathy. Genet Med. 2018;20:275–281. - DOI

Publication types

LinkOut - more resources